Neuraxis to host fourth quarter and full year 2023 results and business update call on tuesday, april 9, 2024

Carmel, ind., april 01, 2024 (globe newswire) -- neuraxis, inc. (“neuraxis,” or the “company”) (nyse american: nrxs), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report financial results for its fourth quarter and fiscal year 2023, for the period ended december 31, 2023, on tuesday, april 9, 2024, after the close of the market. the company has scheduled a conference call for the same day, tuesday, april 9, 2024, at 4:30 pm et to review the results.
NRXS Ratings Summary
NRXS Quant Ranking